The differentiation of the two Entamoeba species E. histolytica and E. dispar through molecular characterization in the last decade of the twentieth century led to the need to re-evaluate the epidemiology of amebiasis in terms of prevalence and morbidity of the infection in the world's population, particularly in those geographic regions with high endemic rates.